Literature DB >> 20027673

Genetic polymorphisms in non-alcoholic fatty liver disease: clues to pathogenesis and disease progression.

Marko Duvnjak, Neven Barsić, Vedran Tomasić, Ivan Lerotić.   

Abstract

The spectrum of non-alcoholic fatty liver disease (NAFLD) ranges from simple steatosis through steatohepatitis to advanced fibrosis and cirrhosis. Although the reason why only a minority of patients develop progressive forms of disease still remains largely unclear, recent research has identified genetic factors as a possible basis for this variation in disease presentation. Most of the studies have been focused on finding associations between advanced disease forms and selected single nucleotide polymorphisms in genes encoding various proteins involved in disease pathogenesis. Although there are many limitations regarding the study design and interpretation of published data, further carefully planned studies together with implementation of new genetic technologies will likely bring new insights into disease pathogenesis and potential benefits to the management of patients with NAFLD.

Entities:  

Mesh:

Year:  2009        PMID: 20027673      PMCID: PMC2797657          DOI: 10.3748/wjg.15.6023

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

1.  Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease.

Authors:  Luca Valenti; Anna Ludovica Fracanzani; Paola Dongiovanni; Gennaro Santorelli; Adriana Branchi; Emanuela Taioli; Gemino Fiorelli; Silvia Fargion
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

2.  Leptin is essential for the hepatic fibrogenic response to chronic liver injury.

Authors:  Isabelle A Leclercq; Geoffrey C Farrell; Rixt Schriemer; Graham R Robertson
Journal:  J Hepatol       Date:  2002-08       Impact factor: 25.083

3.  A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes.

Authors:  K Hara; K Tobe; T Okada; H Kadowaki; Y Akanuma; C Ito; S Kimura; T Kadowaki
Journal:  Diabetologia       Date:  2002-04-23       Impact factor: 10.122

4.  Is NASH underdiagnosed among African Americans?

Authors:  Stephen H Caldwell; Danielle M Harris; James T Patrie; Elizabeth E Hespenheide
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

Review 5.  Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

Authors:  Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2003-02       Impact factor: 4.029

6.  Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha-induced apoptosis in cultured mouse hepatocytes.

Authors:  Hidenari Nagai; Katsuhiko Matsumaru; Guoping Feng; Neil Kaplowitz
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

Review 7.  The human obesity gene map: the 2002 update.

Authors:  Yvon C Chagnon; Tuomo Rankinen; Eric E Snyder; S John Weisnagel; Louis Pérusse; Claude Bouchard
Journal:  Obes Res       Date:  2003-03

8.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.

Authors:  Norikazu Maeda; Iichiro Shimomura; Ken Kishida; Hitoshi Nishizawa; Morihiro Matsuda; Hiroyuki Nagaretani; Naoki Furuyama; Hidehiko Kondo; Masahiko Takahashi; Yukio Arita; Ryutaro Komuro; Noriyuki Ouchi; Shinji Kihara; Yoshihiro Tochino; Keiichi Okutomi; Masato Horie; Satoshi Takeda; Toshifumi Aoyama; Tohru Funahashi; Yuji Matsuzawa
Journal:  Nat Med       Date:  2002-06-17       Impact factor: 53.440

9.  Leptin levels, leptin receptor gene polymorphisms, and energy metabolism in women.

Authors:  Machteld Wauters; Robert V Considine; Monique Chagnon; Ilse Mertens; Tuomo Rankinen; Claude Bouchard; Luc F Van Gaal
Journal:  Obes Res       Date:  2002-05

10.  Polymorphism of human leptin receptor gene is associated with type 2 diabetic patients complicated with non-alcoholic fatty liver disease in China.

Authors:  Hongyun Lu; Jiazhong Sun; Liao Sun; Xiaochun Shu; Yancheng Xu; Danhong Xie
Journal:  J Gastroenterol Hepatol       Date:  2008-08-17       Impact factor: 4.029

View more
  11 in total

Review 1.  Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.

Authors:  Yu-Yuan Li
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

Review 2.  The genetic backgrounds in nonalcoholic fatty liver disease.

Authors:  Yuya Seko; Kanji Yamaguchi; Yoshito Itoh
Journal:  Clin J Gastroenterol       Date:  2018-02-28

Review 3.  Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease.

Authors:  Vettickattuparambil George Giby; Thekkuttuparambil Ananthanarayanan Ajith
Journal:  World J Hepatol       Date:  2014-08-27

4.  AdipoQ T45 G and G276 T Polymorphisms and Susceptibility to Nonalcoholic Fatty Liver Disease Among Asian Populations: A Meta-Analysis and Meta-Regression.

Authors:  Bai-Fang Wang; Ying Wang; Ran Ao; Jing Tong; Bing-Yuan Wang
Journal:  J Clin Lab Anal       Date:  2014-11-10       Impact factor: 2.352

5.  Bioinformatics-driven identification and examination of candidate genes for non-alcoholic fatty liver disease.

Authors:  Karina Banasik; Johanne M Justesen; Malene Hornbak; Nikolaj T Krarup; Anette P Gjesing; Camilla H Sandholt; Thomas S Jensen; Niels Grarup; Asa Andersson; Torben Jørgensen; Daniel R Witte; Annelli Sandbæk; Torsten Lauritzen; Bernard Thorens; Søren Brunak; Thorkild I A Sørensen; Oluf Pedersen; Torben Hansen
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

6.  The PRKAR1B p.R115K Variant is Associated with Lipoprotein Profile in African American Youth with Metabolic Challenges.

Authors:  Michelle Bloyd; Nikolaos Settas; Fabio Rueda Faucz; Ninet Sinaii; Kerstin Bathon; James Iben; Steven Coon; Sonia Caprio; Constantine A Stratakis; Edra London
Journal:  J Endocr Soc       Date:  2021-04-16

7.  Omentin-1 rs2274907 and resistin rs1862513 polymorphisms influence genetic susceptibility to nonalcoholic fatty liver disease.

Authors:  Leila Kohan; Mehrnush Safarpur; Hamed Abdollahi
Journal:  Mol Biol Res Commun       Date:  2016-03

Review 8.  Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients - a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown.

Authors:  Simona Alexandra Iacob; Diana Gabriela Iacob
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-09       Impact factor: 5.555

9.  MTP genetic variants associated with non-alcoholic fatty liver in metabolic syndrome patients.

Authors:  Weaam Gouda; Esmat Ashour; Yehia Shaker; Wafaa Ezzat
Journal:  Genes Dis       Date:  2017-10-16

10.  The Association between SOCS1-1656G>A Polymorphism, Insulin Resistance and Obesity in Nonalcoholic Fatty Liver Disease (NAFLD) Patients.

Authors:  Agnieszka Kempinska-Podhorodecka; Ewa Wunsch; Piotr Milkiewicz; Ewa Stachowska; Malgorzata Milkiewicz
Journal:  J Clin Med       Date:  2019-11-08       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.